Provided by Tiger Trade Technology Pte. Ltd.

Amgen

376.35
+0.70000.19%
Post-market: 375.13-1.2234-0.33%19:59 EDT
Volume:2.40M
Turnover:904.13M
Market Cap:202.66B
PE:23.38
High:379.11
Open:377.01
Low:374.46
Close:375.65
52wk High:447.03
52wk Low:269.77
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.86
T/O Rate:0.45%
Dividend:9.80
Dividend Rate:2.60%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:17.34
PE(LYR):26.45

Loading ...

Amgen EVP, CFO Thomas J.W. Dittrich Files Initial Beneficial Ownership Statement

Reuters
·
Sep 05

Movement Alert|Amgen Falls 5.08% in After-Hours Trading, Trading at $409.94

Market Focus
·
Sep 05

Amgen is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Sep 05

Wells Fargo Adjusts Price Target on Amgen to $435 From $400, Keeps Equalweight Rating

MT Newswires Live
·
Sep 04

Political and General News Events from September 3

Reuters
·
Sep 03

Sino Biopharmaceutical Stock Rises 6.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 03

Amgen to Present at Wells Fargo Healthcare Conference Webcast

Reuters
·
Sep 03

Political and General News Events from September 2

Reuters
·
Sep 02

Investors Shrug Off Good News for Heart Patients from New Meds

Dow Jones
·
Sep 02

Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027

Reuters
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

UK Regulator Suspends Avacopan Vifor for New Patients

MT Newswires Live
·
Sep 01

UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September

THOMSON REUTERS
·
Sep 01

Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?

Simply Wall St.
·
Sep 01

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Reuters
·
Sep 01

Political and General News Events from August 31

Reuters
·
Aug 31

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live
·
Aug 31

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

TIPRANKS
·
Aug 31

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS
·
Aug 31

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29